NCT07010315Recruiting
Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention
Source: ClinicalTrials.gov · Last updated 6 Aug 2026
Brief summary (registry, in English)
To develop and test liver cancer prevention educational material.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 40 (estimated)
- First submitted
- 9 May 2025
- Start date
- 1 May 2025
- Primary completion date
- 30 Apr 2027
- Lead sponsor
- M.D. Anderson Cancer Center
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT07010315
What you commit to
- Study type: Observational
- Planned participants: 40
- From 1 May 2025 to the primary completion date, 30 Apr 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Has been diagnosed with liver cancer
- Cannot provide consent or otherwise participate in research activities (e.g. vision or hearing impairment)
Who the study is looking for
- At least 18 years old
- Participants at the HOPE Clinic
- Able to speak and read either English or Spanish
- For usability testing: Able to use and navigate websites on own smart phone or study computer
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| MD Anderson Cancer Center Coordinator of this site? Confirm its status | Houston | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.